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
Fokustema
Nordiska dopingkommittén
Läs senare
Förlänger och förkortar karenstid
Den nordiska dopingkommittén Nemac har beslutat att göra en del förändringar gällande karenstider. För substansen mepivacain förlängs karenstiden från fyra dygn till minst sex dygn. Samtidigt förkortas bland annat tiden för dexametason-natriumfosfat i led från 28 till minst 14 dygn. Den nya ordningen gäller från den 3 september i år.
